nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0712	0.139	CbGbCtD
Doxepin—CYP2C19—Progesterone—uterine cancer	0.0567	0.111	CbGbCtD
Doxepin—CYP1A2—Progesterone—uterine cancer	0.0524	0.102	CbGbCtD
Doxepin—CYP2C9—Progesterone—uterine cancer	0.0472	0.0919	CbGbCtD
Doxepin—ABCB1—Progesterone—uterine cancer	0.0458	0.0892	CbGbCtD
Doxepin—CYP2D6—Progesterone—uterine cancer	0.0431	0.084	CbGbCtD
Doxepin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0414	0.0807	CbGbCtD
Doxepin—ABCB1—Dactinomycin—uterine cancer	0.0363	0.0707	CbGbCtD
Doxepin—CYP3A4—Progesterone—uterine cancer	0.0274	0.0534	CbGbCtD
Doxepin—CYP1A2—Etoposide—uterine cancer	0.0234	0.0456	CbGbCtD
Doxepin—ABCB1—Etoposide—uterine cancer	0.0205	0.0399	CbGbCtD
Doxepin—CHRM3—ureter—uterine cancer	0.0143	0.13	CbGeAlD
Doxepin—ABCB1—Doxorubicin—uterine cancer	0.014	0.0272	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—uterine cancer	0.0132	0.0257	CbGbCtD
Doxepin—CYP3A4—Etoposide—uterine cancer	0.0123	0.0239	CbGbCtD
Doxepin—CHRM3—muscle of abdomen—uterine cancer	0.0103	0.0933	CbGeAlD
Doxepin—CYP3A4—Doxorubicin—uterine cancer	0.00837	0.0163	CbGbCtD
Doxepin—CHRM3—exocrine gland—uterine cancer	0.00282	0.0255	CbGeAlD
Doxepin—CHRM5—epithelium—uterine cancer	0.0022	0.0199	CbGeAlD
Doxepin—ADRA1D—epithelium—uterine cancer	0.00196	0.0178	CbGeAlD
Doxepin—HTR2A—artery—uterine cancer	0.00192	0.0174	CbGeAlD
Doxepin—ADRA1B—renal system—uterine cancer	0.00186	0.0168	CbGeAlD
Doxepin—HTR2B—myometrium—uterine cancer	0.00174	0.0157	CbGeAlD
Doxepin—ADRA1D—female reproductive system—uterine cancer	0.00146	0.0132	CbGeAlD
Doxepin—ORM1—endometrium—uterine cancer	0.00145	0.0131	CbGeAlD
Doxepin—KCNH2—myometrium—uterine cancer	0.00139	0.0126	CbGeAlD
Doxepin—ADRA2C—myometrium—uterine cancer	0.00137	0.0124	CbGeAlD
Doxepin—HTR2B—uterine cervix—uterine cancer	0.00135	0.0122	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—uterine cancer	0.00132	0.0119	CbGeAlD
Doxepin—HTR2B—decidua—uterine cancer	0.00129	0.0117	CbGeAlD
Doxepin—HTR2B—endometrium—uterine cancer	0.00122	0.0111	CbGeAlD
Doxepin—ORM1—female reproductive system—uterine cancer	0.0012	0.0109	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—uterine cancer	0.00118	0.0107	CbGeAlD
Doxepin—SLC6A2—decidua—uterine cancer	0.00115	0.0104	CbGeAlD
Doxepin—CHRM3—renal system—uterine cancer	0.00114	0.0103	CbGeAlD
Doxepin—HTR1A—renal system—uterine cancer	0.00113	0.0103	CbGeAlD
Doxepin—HTR2B—uterus—uterine cancer	0.00113	0.0102	CbGeAlD
Doxepin—ADRA1A—epithelium—uterine cancer	0.00113	0.0102	CbGeAlD
Doxepin—HRH1—myometrium—uterine cancer	0.00111	0.0101	CbGeAlD
Doxepin—ADRA2A—myometrium—uterine cancer	0.00109	0.00988	CbGeAlD
Doxepin—KCNH2—uterine cervix—uterine cancer	0.00108	0.00977	CbGeAlD
Doxepin—HTR2C—female reproductive system—uterine cancer	0.00108	0.00977	CbGeAlD
Doxepin—ADRA2C—uterine cervix—uterine cancer	0.00107	0.00964	CbGeAlD
Doxepin—ADRA1A—renal system—uterine cancer	0.00105	0.00946	CbGeAlD
Doxepin—SLC6A4—female reproductive system—uterine cancer	0.00102	0.00926	CbGeAlD
Doxepin—CHRM1—female reproductive system—uterine cancer	0.00102	0.00922	CbGeAlD
Doxepin—ADRA2C—decidua—uterine cancer	0.00101	0.00918	CbGeAlD
Doxepin—HTR2B—female reproductive system—uterine cancer	0.00101	0.00918	CbGeAlD
Doxepin—KCNH2—renal system—uterine cancer	0.00101	0.00914	CbGeAlD
Doxepin—HRH2—lymph node—uterine cancer	0.000999	0.00904	CbGeAlD
Doxepin—ADRA2C—renal system—uterine cancer	0.000996	0.00902	CbGeAlD
Doxepin—KCNH2—endometrium—uterine cancer	0.000976	0.00884	CbGeAlD
Doxepin—ADRA2C—endometrium—uterine cancer	0.000963	0.00872	CbGeAlD
Doxepin—ADRA2C—mammalian vulva—uterine cancer	0.000932	0.00843	CbGeAlD
Doxepin—HTR2B—vagina—uterine cancer	0.000917	0.0083	CbGeAlD
Doxepin—CHRM3—female reproductive system—uterine cancer	0.000912	0.00825	CbGeAlD
Doxepin—SLC6A2—female reproductive system—uterine cancer	0.000901	0.00815	CbGeAlD
Doxepin—KCNH2—uterus—uterine cancer	0.0009	0.00814	CbGeAlD
Doxepin—ADRA2C—uterus—uterine cancer	0.000888	0.00803	CbGeAlD
Doxepin—HRH1—epithelium—uterine cancer	0.000873	0.0079	CbGeAlD
Doxepin—HRH1—uterine cervix—uterine cancer	0.000865	0.00783	CbGeAlD
Doxepin—CYP1A2—renal system—uterine cancer	0.000865	0.00782	CbGeAlD
Doxepin—ADRA2A—uterine cervix—uterine cancer	0.00085	0.00769	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—uterine cancer	0.000841	0.00761	CbGeAlD
Doxepin—CHRM3—female gonad—uterine cancer	0.00083	0.00751	CbGeAlD
Doxepin—HRH1—decidua—uterine cancer	0.000824	0.00746	CbGeAlD
Doxepin—ADRA2A—decidua—uterine cancer	0.00081	0.00733	CbGeAlD
Doxepin—KCNH2—female reproductive system—uterine cancer	0.000809	0.00732	CbGeAlD
Doxepin—HRH1—endometrium—uterine cancer	0.000783	0.00708	CbGeAlD
Doxepin—ADRA2A—endometrium—uterine cancer	0.000769	0.00696	CbGeAlD
Doxepin—CYP2C19—vagina—uterine cancer	0.000767	0.00694	CbGeAlD
Doxepin—HRH1—mammalian vulva—uterine cancer	0.000757	0.00685	CbGeAlD
Doxepin—ADRA2A—mammalian vulva—uterine cancer	0.000744	0.00673	CbGeAlD
Doxepin—KCNH2—female gonad—uterine cancer	0.000736	0.00666	CbGeAlD
Doxepin—KCNH2—vagina—uterine cancer	0.000732	0.00662	CbGeAlD
Doxepin—HTR2A—epithelium—uterine cancer	0.000729	0.0066	CbGeAlD
Doxepin—ADRA2C—female gonad—uterine cancer	0.000726	0.00657	CbGeAlD
Doxepin—ADRA2C—vagina—uterine cancer	0.000722	0.00653	CbGeAlD
Doxepin—ADRA2A—uterus—uterine cancer	0.000708	0.00641	CbGeAlD
Doxepin—ORM1—lymph node—uterine cancer	0.000702	0.00636	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—uterine cancer	0.000702	0.00636	CbGeAlD
Doxepin—HTR2A—renal system—uterine cancer	0.000676	0.00612	CbGeAlD
Doxepin—CYP2C9—female reproductive system—uterine cancer	0.000657	0.00595	CbGeAlD
Doxepin—HRH1—female reproductive system—uterine cancer	0.000648	0.00587	CbGeAlD
Doxepin—ADRA2A—female reproductive system—uterine cancer	0.000637	0.00576	CbGeAlD
Doxepin—CYP3A4—renal system—uterine cancer	0.000626	0.00566	CbGeAlD
Doxepin—CYP2D6—renal system—uterine cancer	0.000616	0.00557	CbGeAlD
Doxepin—ABCB1—myometrium—uterine cancer	0.000609	0.00551	CbGeAlD
Doxepin—HTR2B—lymph node—uterine cancer	0.000593	0.00537	CbGeAlD
Doxepin—HRH1—female gonad—uterine cancer	0.00059	0.00534	CbGeAlD
Doxepin—HRH1—vagina—uterine cancer	0.000586	0.00531	CbGeAlD
Doxepin—ADRA2A—female gonad—uterine cancer	0.000579	0.00524	CbGeAlD
Doxepin—ADRA2A—vagina—uterine cancer	0.000576	0.00521	CbGeAlD
Doxepin—HTR2A—female reproductive system—uterine cancer	0.000541	0.0049	CbGeAlD
Doxepin—SLC6A2—lymph node—uterine cancer	0.000527	0.00477	CbGeAlD
Doxepin—CYP3A4—female reproductive system—uterine cancer	0.000501	0.00454	CbGeAlD
Doxepin—CYP2D6—female reproductive system—uterine cancer	0.000493	0.00446	CbGeAlD
Doxepin—HTR2A—vagina—uterine cancer	0.00049	0.00443	CbGeAlD
Doxepin—ABCB1—epithelium—uterine cancer	0.000478	0.00432	CbGeAlD
Doxepin—ABCB1—uterine cervix—uterine cancer	0.000474	0.00429	CbGeAlD
Doxepin—KCNH2—lymph node—uterine cancer	0.000473	0.00428	CbGeAlD
Doxepin—ADRA2C—lymph node—uterine cancer	0.000467	0.00422	CbGeAlD
Doxepin—ABCB1—decidua—uterine cancer	0.000451	0.00408	CbGeAlD
Doxepin—CYP2D6—female gonad—uterine cancer	0.000449	0.00406	CbGeAlD
Doxepin—ABCB1—renal system—uterine cancer	0.000443	0.00401	CbGeAlD
Doxepin—ABCB1—endometrium—uterine cancer	0.000428	0.00388	CbGeAlD
Doxepin—ABCB1—mammalian vulva—uterine cancer	0.000414	0.00375	CbGeAlD
Doxepin—ABCB1—uterus—uterine cancer	0.000395	0.00357	CbGeAlD
Doxepin—HRH1—lymph node—uterine cancer	0.000379	0.00343	CbGeAlD
Doxepin—ADRA2A—lymph node—uterine cancer	0.000372	0.00337	CbGeAlD
Doxepin—ABCB1—female reproductive system—uterine cancer	0.000355	0.00321	CbGeAlD
Doxepin—ABCB1—female gonad—uterine cancer	0.000323	0.00292	CbGeAlD
Doxepin—ABCB1—vagina—uterine cancer	0.000321	0.0029	CbGeAlD
Doxepin—Infection—Etoposide—uterine cancer	0.000279	0.000789	CcSEcCtD
Doxepin—Ataxia—Doxorubicin—uterine cancer	0.000279	0.000788	CcSEcCtD
Doxepin—Asthenia—Dactinomycin—uterine cancer	0.000279	0.000787	CcSEcCtD
Doxepin—Influenza—Epirubicin—uterine cancer	0.000277	0.000783	CcSEcCtD
Doxepin—Asthma—Epirubicin—uterine cancer	0.000277	0.000783	CcSEcCtD
Doxepin—Thrombocytopenia—Etoposide—uterine cancer	0.000275	0.000778	CcSEcCtD
Doxepin—Tachycardia—Etoposide—uterine cancer	0.000274	0.000775	CcSEcCtD
Doxepin—Eosinophilia—Epirubicin—uterine cancer	0.000274	0.000775	CcSEcCtD
Doxepin—Skin disorder—Etoposide—uterine cancer	0.000273	0.000772	CcSEcCtD
Doxepin—Hyperhidrosis—Etoposide—uterine cancer	0.000272	0.000768	CcSEcCtD
Doxepin—Hypokalaemia—Doxorubicin—uterine cancer	0.00027	0.000763	CcSEcCtD
Doxepin—Breast disorder—Doxorubicin—uterine cancer	0.000268	0.000758	CcSEcCtD
Doxepin—Anorexia—Etoposide—uterine cancer	0.000268	0.000757	CcSEcCtD
Doxepin—Bronchitis—Epirubicin—uterine cancer	0.000267	0.000753	CcSEcCtD
Doxepin—Diarrhoea—Dactinomycin—uterine cancer	0.000266	0.000751	CcSEcCtD
Doxepin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000265	0.00075	CcSEcCtD
Doxepin—Pancytopenia—Epirubicin—uterine cancer	0.000263	0.000744	CcSEcCtD
Doxepin—Hypotension—Etoposide—uterine cancer	0.000263	0.000742	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000262	0.000739	CcSEcCtD
Doxepin—Dysuria—Epirubicin—uterine cancer	0.000259	0.000732	CcSEcCtD
Doxepin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000258	0.000728	CcSEcCtD
Doxepin—Asthma—Doxorubicin—uterine cancer	0.000256	0.000724	CcSEcCtD
Doxepin—Influenza—Doxorubicin—uterine cancer	0.000256	0.000724	CcSEcCtD
Doxepin—Pollakiuria—Epirubicin—uterine cancer	0.000256	0.000723	CcSEcCtD
Doxepin—Eosinophilia—Doxorubicin—uterine cancer	0.000254	0.000717	CcSEcCtD
Doxepin—Paraesthesia—Etoposide—uterine cancer	0.000252	0.000713	CcSEcCtD
Doxepin—Weight increased—Epirubicin—uterine cancer	0.000252	0.000713	CcSEcCtD
Doxepin—Dyspnoea—Etoposide—uterine cancer	0.000251	0.000708	CcSEcCtD
Doxepin—Somnolence—Etoposide—uterine cancer	0.00025	0.000706	CcSEcCtD
Doxepin—Pneumonia—Epirubicin—uterine cancer	0.000249	0.000702	CcSEcCtD
Doxepin—Infestation—Epirubicin—uterine cancer	0.000247	0.000698	CcSEcCtD
Doxepin—Infestation NOS—Epirubicin—uterine cancer	0.000247	0.000698	CcSEcCtD
Doxepin—Drowsiness—Epirubicin—uterine cancer	0.000247	0.000698	CcSEcCtD
Doxepin—Vomiting—Dactinomycin—uterine cancer	0.000247	0.000698	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—uterine cancer	0.000247	0.000697	CcSEcCtD
Doxepin—Rash—Dactinomycin—uterine cancer	0.000245	0.000692	CcSEcCtD
Doxepin—Decreased appetite—Etoposide—uterine cancer	0.000244	0.000691	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—uterine cancer	0.000244	0.000688	CcSEcCtD
Doxepin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000243	0.000686	CcSEcCtD
Doxepin—Fatigue—Etoposide—uterine cancer	0.000242	0.000685	CcSEcCtD
Doxepin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000242	0.000684	CcSEcCtD
Doxepin—Stomatitis—Epirubicin—uterine cancer	0.000241	0.000681	CcSEcCtD
Doxepin—Jaundice—Epirubicin—uterine cancer	0.000241	0.000681	CcSEcCtD
Doxepin—Pain—Etoposide—uterine cancer	0.00024	0.000679	CcSEcCtD
Doxepin—Constipation—Etoposide—uterine cancer	0.00024	0.000679	CcSEcCtD
Doxepin—Urinary tract infection—Epirubicin—uterine cancer	0.00024	0.000679	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—uterine cancer	0.00024	0.000677	CcSEcCtD
Doxepin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000238	0.000673	CcSEcCtD
Doxepin—Sweating—Epirubicin—uterine cancer	0.000237	0.000669	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—uterine cancer	0.000237	0.000669	CcSEcCtD
Doxepin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000234	0.00066	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—uterine cancer	0.000233	0.000659	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—uterine cancer	0.000232	0.000655	CcSEcCtD
Doxepin—Feeling abnormal—Etoposide—uterine cancer	0.000232	0.000655	CcSEcCtD
Doxepin—Nausea—Dactinomycin—uterine cancer	0.000231	0.000652	CcSEcCtD
Doxepin—Agranulocytosis—Epirubicin—uterine cancer	0.000231	0.000652	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—uterine cancer	0.00023	0.00065	CcSEcCtD
Doxepin—Gastrointestinal pain—Etoposide—uterine cancer	0.00023	0.00065	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—uterine cancer	0.000229	0.000646	CcSEcCtD
Doxepin—Infestation—Doxorubicin—uterine cancer	0.000229	0.000646	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—uterine cancer	0.000229	0.000646	CcSEcCtD
Doxepin—Bradycardia—Epirubicin—uterine cancer	0.000226	0.000638	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000224	0.000633	CcSEcCtD
Doxepin—Urticaria—Etoposide—uterine cancer	0.000223	0.000631	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—uterine cancer	0.000223	0.00063	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—uterine cancer	0.000223	0.00063	CcSEcCtD
Doxepin—Abdominal pain—Etoposide—uterine cancer	0.000222	0.000628	CcSEcCtD
Doxepin—Body temperature increased—Etoposide—uterine cancer	0.000222	0.000628	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—uterine cancer	0.000222	0.000628	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—uterine cancer	0.000222	0.000627	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—uterine cancer	0.000221	0.000624	CcSEcCtD
Doxepin—Pharyngitis—Epirubicin—uterine cancer	0.00022	0.000622	CcSEcCtD
Doxepin—Sweating—Doxorubicin—uterine cancer	0.000219	0.000619	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—uterine cancer	0.000219	0.000619	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—uterine cancer	0.000219	0.000617	CcSEcCtD
Doxepin—Connective tissue disorder—Epirubicin—uterine cancer	0.000218	0.000616	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—uterine cancer	0.000217	0.000614	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000216	0.000611	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—uterine cancer	0.000215	0.000606	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—uterine cancer	0.000213	0.000603	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—uterine cancer	0.000209	0.00059	CcSEcCtD
Doxepin—ABCB1—lymph node—uterine cancer	0.000208	0.00188	CbGeAlD
Doxepin—Eye disorder—Epirubicin—uterine cancer	0.000207	0.000586	CcSEcCtD
Doxepin—Hypersensitivity—Etoposide—uterine cancer	0.000207	0.000585	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—uterine cancer	0.000207	0.000584	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—uterine cancer	0.000206	0.000582	CcSEcCtD
Doxepin—Flushing—Epirubicin—uterine cancer	0.000206	0.000582	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—uterine cancer	0.000205	0.00058	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000204	0.000577	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—uterine cancer	0.000204	0.000576	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000203	0.000573	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—uterine cancer	0.000202	0.000571	CcSEcCtD
Doxepin—Asthenia—Etoposide—uterine cancer	0.000202	0.00057	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000202	0.00057	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—uterine cancer	0.000201	0.000569	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—uterine cancer	0.000201	0.000568	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—uterine cancer	0.0002	0.000566	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—uterine cancer	0.0002	0.000565	CcSEcCtD
Doxepin—Chills—Epirubicin—uterine cancer	0.000199	0.000562	CcSEcCtD
Doxepin—Pruritus—Etoposide—uterine cancer	0.000199	0.000562	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—uterine cancer	0.000198	0.00056	CcSEcCtD
Doxepin—Alopecia—Epirubicin—uterine cancer	0.000196	0.000554	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—uterine cancer	0.000194	0.000549	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—uterine cancer	0.000193	0.000546	CcSEcCtD
Doxepin—Erythema—Epirubicin—uterine cancer	0.000193	0.000546	CcSEcCtD
Doxepin—Diarrhoea—Etoposide—uterine cancer	0.000192	0.000544	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—uterine cancer	0.000192	0.000542	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—uterine cancer	0.000191	0.000541	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—uterine cancer	0.000191	0.000538	CcSEcCtD
Doxepin—Flushing—Doxorubicin—uterine cancer	0.000191	0.000538	CcSEcCtD
Doxepin—Flatulence—Epirubicin—uterine cancer	0.00019	0.000538	CcSEcCtD
Doxepin—Tension—Epirubicin—uterine cancer	0.00019	0.000535	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—uterine cancer	0.000189	0.000534	CcSEcCtD
Doxepin—Nervousness—Epirubicin—uterine cancer	0.000188	0.00053	CcSEcCtD
Doxepin—Back pain—Epirubicin—uterine cancer	0.000187	0.000528	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—uterine cancer	0.000186	0.000526	CcSEcCtD
Doxepin—Dizziness—Etoposide—uterine cancer	0.000186	0.000525	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—uterine cancer	0.000186	0.000525	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—uterine cancer	0.000185	0.000524	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000185	0.000523	CcSEcCtD
Doxepin—Chills—Doxorubicin—uterine cancer	0.000184	0.00052	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—uterine cancer	0.000183	0.000518	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—uterine cancer	0.000182	0.000514	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—uterine cancer	0.000181	0.000512	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—uterine cancer	0.00018	0.000508	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—uterine cancer	0.000179	0.000506	CcSEcCtD
Doxepin—Vomiting—Etoposide—uterine cancer	0.000179	0.000505	CcSEcCtD
Doxepin—Erythema—Doxorubicin—uterine cancer	0.000179	0.000505	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—uterine cancer	0.000179	0.000505	CcSEcCtD
Doxepin—Anaemia—Epirubicin—uterine cancer	0.000178	0.000504	CcSEcCtD
Doxepin—Agitation—Epirubicin—uterine cancer	0.000177	0.000501	CcSEcCtD
Doxepin—Rash—Etoposide—uterine cancer	0.000177	0.000501	CcSEcCtD
Doxepin—Dermatitis—Etoposide—uterine cancer	0.000177	0.0005	CcSEcCtD
Doxepin—Headache—Etoposide—uterine cancer	0.000176	0.000498	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—uterine cancer	0.000176	0.000497	CcSEcCtD
Doxepin—Tension—Doxorubicin—uterine cancer	0.000175	0.000495	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—uterine cancer	0.000175	0.000494	CcSEcCtD
Doxepin—Malaise—Epirubicin—uterine cancer	0.000174	0.000492	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—uterine cancer	0.000174	0.00049	CcSEcCtD
Doxepin—Vertigo—Epirubicin—uterine cancer	0.000174	0.00049	CcSEcCtD
Doxepin—Syncope—Epirubicin—uterine cancer	0.000173	0.000489	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—uterine cancer	0.000173	0.000488	CcSEcCtD
Doxepin—Back pain—Doxorubicin—uterine cancer	0.000173	0.000488	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—uterine cancer	0.000172	0.000485	CcSEcCtD
Doxepin—Palpitations—Epirubicin—uterine cancer	0.000171	0.000482	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—uterine cancer	0.00017	0.00048	CcSEcCtD
Doxepin—Cough—Epirubicin—uterine cancer	0.000169	0.000476	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—uterine cancer	0.000168	0.000476	CcSEcCtD
Doxepin—Convulsion—Epirubicin—uterine cancer	0.000167	0.000473	CcSEcCtD
Doxepin—Nausea—Etoposide—uterine cancer	0.000167	0.000472	CcSEcCtD
Doxepin—Hypertension—Epirubicin—uterine cancer	0.000167	0.000471	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000166	0.000468	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—uterine cancer	0.000165	0.000467	CcSEcCtD
Doxepin—Myalgia—Epirubicin—uterine cancer	0.000164	0.000464	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—uterine cancer	0.000164	0.000464	CcSEcCtD
Doxepin—Chest pain—Epirubicin—uterine cancer	0.000164	0.000464	CcSEcCtD
Doxepin—Agitation—Doxorubicin—uterine cancer	0.000164	0.000464	CcSEcCtD
Doxepin—Anxiety—Epirubicin—uterine cancer	0.000164	0.000463	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000163	0.000461	CcSEcCtD
Doxepin—Discomfort—Epirubicin—uterine cancer	0.000162	0.000459	CcSEcCtD
Doxepin—Malaise—Doxorubicin—uterine cancer	0.000161	0.000455	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—uterine cancer	0.000161	0.000454	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—uterine cancer	0.000161	0.000454	CcSEcCtD
Doxepin—Syncope—Doxorubicin—uterine cancer	0.00016	0.000453	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—uterine cancer	0.00016	0.000452	CcSEcCtD
Doxepin—Confusional state—Epirubicin—uterine cancer	0.000159	0.000449	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—uterine cancer	0.000158	0.000446	CcSEcCtD
Doxepin—Oedema—Epirubicin—uterine cancer	0.000158	0.000445	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—uterine cancer	0.000157	0.000444	CcSEcCtD
Doxepin—Infection—Epirubicin—uterine cancer	0.000157	0.000442	CcSEcCtD
Doxepin—Cough—Doxorubicin—uterine cancer	0.000156	0.000441	CcSEcCtD
Doxepin—Shock—Epirubicin—uterine cancer	0.000155	0.000438	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—uterine cancer	0.000155	0.000437	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—uterine cancer	0.000155	0.000437	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—uterine cancer	0.000154	0.000436	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—uterine cancer	0.000154	0.000436	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—uterine cancer	0.000154	0.000435	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—uterine cancer	0.000153	0.000433	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—uterine cancer	0.000152	0.00043	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—uterine cancer	0.000152	0.00043	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—uterine cancer	0.000152	0.00043	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—uterine cancer	0.000152	0.00043	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—uterine cancer	0.000152	0.000428	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000151	0.000427	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—uterine cancer	0.00015	0.000425	CcSEcCtD
Doxepin—Anorexia—Epirubicin—uterine cancer	0.00015	0.000424	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—uterine cancer	0.000149	0.00042	CcSEcCtD
Doxepin—Hypotension—Epirubicin—uterine cancer	0.000147	0.000416	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—uterine cancer	0.000147	0.000415	CcSEcCtD
Doxepin—Oedema—Doxorubicin—uterine cancer	0.000146	0.000412	CcSEcCtD
Doxepin—Infection—Doxorubicin—uterine cancer	0.000145	0.000409	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000144	0.000406	CcSEcCtD
Doxepin—Shock—Doxorubicin—uterine cancer	0.000143	0.000405	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—uterine cancer	0.000143	0.000404	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000143	0.000403	CcSEcCtD
Doxepin—Insomnia—Epirubicin—uterine cancer	0.000143	0.000403	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—uterine cancer	0.000142	0.000402	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—uterine cancer	0.000142	0.0004	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—uterine cancer	0.000142	0.0004	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000141	0.000398	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—uterine cancer	0.000141	0.000397	CcSEcCtD
Doxepin—Somnolence—Epirubicin—uterine cancer	0.00014	0.000396	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—uterine cancer	0.000139	0.000393	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—uterine cancer	0.000139	0.000392	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—uterine cancer	0.000137	0.000387	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—uterine cancer	0.000136	0.000385	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000136	0.000384	CcSEcCtD
Doxepin—Fatigue—Epirubicin—uterine cancer	0.000136	0.000384	CcSEcCtD
Doxepin—Pain—Epirubicin—uterine cancer	0.000135	0.000381	CcSEcCtD
Doxepin—Constipation—Epirubicin—uterine cancer	0.000135	0.000381	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000133	0.000375	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—uterine cancer	0.000132	0.000373	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—uterine cancer	0.000131	0.00037	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—uterine cancer	0.00013	0.000367	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—uterine cancer	0.00013	0.000367	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—uterine cancer	0.00013	0.000366	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000129	0.000364	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—uterine cancer	0.000128	0.000363	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—uterine cancer	0.000127	0.000358	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000126	0.000356	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—uterine cancer	0.000126	0.000355	CcSEcCtD
Doxepin—Urticaria—Epirubicin—uterine cancer	0.000125	0.000354	CcSEcCtD
Doxepin—Pain—Doxorubicin—uterine cancer	0.000125	0.000352	CcSEcCtD
Doxepin—Constipation—Doxorubicin—uterine cancer	0.000125	0.000352	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—uterine cancer	0.000125	0.000352	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—uterine cancer	0.000125	0.000352	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—uterine cancer	0.00012	0.00034	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000119	0.000337	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—uterine cancer	0.000116	0.000328	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—uterine cancer	0.000116	0.000327	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—uterine cancer	0.000115	0.000326	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—uterine cancer	0.000115	0.000326	CcSEcCtD
Doxepin—Asthenia—Epirubicin—uterine cancer	0.000113	0.000319	CcSEcCtD
Doxepin—Pruritus—Epirubicin—uterine cancer	0.000112	0.000315	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—uterine cancer	0.000108	0.000305	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—uterine cancer	0.000107	0.000304	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—uterine cancer	0.000105	0.000296	CcSEcCtD
Doxepin—Dizziness—Epirubicin—uterine cancer	0.000104	0.000294	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—uterine cancer	0.000103	0.000291	CcSEcCtD
Doxepin—Vomiting—Epirubicin—uterine cancer	0.0001	0.000283	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—uterine cancer	9.98e-05	0.000282	CcSEcCtD
Doxepin—Rash—Epirubicin—uterine cancer	9.94e-05	0.000281	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—uterine cancer	9.93e-05	0.00028	CcSEcCtD
Doxepin—Headache—Epirubicin—uterine cancer	9.87e-05	0.000279	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—uterine cancer	9.64e-05	0.000272	CcSEcCtD
Doxepin—Nausea—Epirubicin—uterine cancer	9.36e-05	0.000264	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—uterine cancer	9.27e-05	0.000262	CcSEcCtD
Doxepin—Rash—Doxorubicin—uterine cancer	9.2e-05	0.00026	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—uterine cancer	9.19e-05	0.00026	CcSEcCtD
Doxepin—Headache—Doxorubicin—uterine cancer	9.14e-05	0.000258	CcSEcCtD
Doxepin—Nausea—Doxorubicin—uterine cancer	8.66e-05	0.000245	CcSEcCtD
Doxepin—ADRA1D—Signaling Pathways—NRAS—uterine cancer	3.26e-06	0.000146	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	3.26e-06	0.000146	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	3.26e-06	0.000146	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	3.25e-06	0.000146	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	3.25e-06	0.000146	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—uterine cancer	3.23e-06	0.000145	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ERBB2—uterine cancer	3.23e-06	0.000145	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	3.23e-06	0.000145	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ERBB2—uterine cancer	3.22e-06	0.000145	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—uterine cancer	3.22e-06	0.000145	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	3.22e-06	0.000145	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ERBB2—uterine cancer	3.21e-06	0.000144	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ERBB2—uterine cancer	3.2e-06	0.000144	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTEN—uterine cancer	3.19e-06	0.000143	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTEN—uterine cancer	3.17e-06	0.000142	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ERBB2—uterine cancer	3.17e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	3.16e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	3.16e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EP300—uterine cancer	3.15e-06	0.000141	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KRAS—uterine cancer	3.12e-06	0.00014	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	3.11e-06	0.00014	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—EP300—uterine cancer	3.11e-06	0.00014	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL8—uterine cancer	3.11e-06	0.00014	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—uterine cancer	3.11e-06	0.00014	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—uterine cancer	3.09e-06	0.000139	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—HRAS—uterine cancer	3.09e-06	0.000139	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTEN—uterine cancer	3.08e-06	0.000138	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.06e-06	0.000138	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—uterine cancer	3.06e-06	0.000137	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—uterine cancer	3.05e-06	0.000137	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—STK11—uterine cancer	3.05e-06	0.000137	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.05e-06	0.000137	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—uterine cancer	3.04e-06	0.000137	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—HRAS—uterine cancer	3.04e-06	0.000137	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EP300—uterine cancer	3.04e-06	0.000136	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1B—uterine cancer	3.04e-06	0.000136	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—uterine cancer	3.04e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—uterine cancer	3.03e-06	0.000136	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—HRAS—uterine cancer	3.03e-06	0.000136	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTEN—uterine cancer	3.03e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—HRAS—uterine cancer	3.02e-06	0.000136	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EP300—uterine cancer	3.02e-06	0.000136	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KRAS—uterine cancer	3.02e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—HRAS—uterine cancer	3.02e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	3.01e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—uterine cancer	3.01e-06	0.000135	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—uterine cancer	3.01e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	3e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTEN—uterine cancer	2.99e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.99e-06	0.000134	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	2.99e-06	0.000134	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—HRAS—uterine cancer	2.99e-06	0.000134	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KRAS—uterine cancer	2.99e-06	0.000134	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1B—uterine cancer	2.98e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—uterine cancer	2.98e-06	0.000134	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	2.98e-06	0.000134	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	2.97e-06	0.000134	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—uterine cancer	2.97e-06	0.000133	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	2.96e-06	0.000133	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	2.96e-06	0.000133	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	2.96e-06	0.000133	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—uterine cancer	2.95e-06	0.000133	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NRAS—uterine cancer	2.94e-06	0.000132	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	2.94e-06	0.000132	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EP300—uterine cancer	2.94e-06	0.000132	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—uterine cancer	2.94e-06	0.000132	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.94e-06	0.000132	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	2.93e-06	0.000132	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	2.93e-06	0.000132	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	2.93e-06	0.000131	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	2.9e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	2.9e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EP300—uterine cancer	2.89e-06	0.00013	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—uterine cancer	2.88e-06	0.000129	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CTNNB1—uterine cancer	2.87e-06	0.000129	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	2.86e-06	0.000129	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—uterine cancer	2.86e-06	0.000129	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—EP300—uterine cancer	2.86e-06	0.000128	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NRAS—uterine cancer	2.84e-06	0.000128	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NRAS—uterine cancer	2.83e-06	0.000127	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	2.82e-06	0.000127	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—uterine cancer	2.82e-06	0.000127	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—HRAS—uterine cancer	2.81e-06	0.000126	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	2.81e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—uterine cancer	2.81e-06	0.000126	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	2.8e-06	0.000126	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—uterine cancer	2.8e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	2.78e-06	0.000125	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	2.78e-06	0.000125	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	2.77e-06	0.000125	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	2.77e-06	0.000124	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—uterine cancer	2.77e-06	0.000124	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	2.77e-06	0.000124	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	2.77e-06	0.000124	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—uterine cancer	2.75e-06	0.000124	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NRAS—uterine cancer	2.75e-06	0.000124	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—uterine cancer	2.75e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	2.74e-06	0.000123	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	2.74e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—uterine cancer	2.74e-06	0.000123	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—uterine cancer	2.73e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—uterine cancer	2.73e-06	0.000123	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	2.72e-06	0.000122	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NRAS—uterine cancer	2.71e-06	0.000122	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—uterine cancer	2.7e-06	0.000121	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—uterine cancer	2.7e-06	0.000121	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	2.69e-06	0.000121	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—uterine cancer	2.69e-06	0.000121	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—uterine cancer	2.68e-06	0.00012	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—uterine cancer	2.68e-06	0.00012	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—uterine cancer	2.67e-06	0.00012	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—uterine cancer	2.67e-06	0.00012	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—uterine cancer	2.66e-06	0.00012	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—uterine cancer	2.65e-06	0.000119	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—uterine cancer	2.65e-06	0.000119	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—uterine cancer	2.64e-06	0.000118	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	2.63e-06	0.000118	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—uterine cancer	2.62e-06	0.000118	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—uterine cancer	2.62e-06	0.000118	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.62e-06	0.000118	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—uterine cancer	2.61e-06	0.000117	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—uterine cancer	2.6e-06	0.000117	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—uterine cancer	2.6e-06	0.000117	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—uterine cancer	2.58e-06	0.000116	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—uterine cancer	2.58e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—uterine cancer	2.57e-06	0.000115	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	2.57e-06	0.000115	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—uterine cancer	2.56e-06	0.000115	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—uterine cancer	2.54e-06	0.000114	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—uterine cancer	2.53e-06	0.000114	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—uterine cancer	2.53e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—uterine cancer	2.5e-06	0.000112	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NRAS—uterine cancer	2.5e-06	0.000112	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—uterine cancer	2.49e-06	0.000112	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—uterine cancer	2.49e-06	0.000112	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—uterine cancer	2.48e-06	0.000111	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—uterine cancer	2.48e-06	0.000111	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—uterine cancer	2.47e-06	0.000111	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—uterine cancer	2.46e-06	0.000111	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NRAS—uterine cancer	2.46e-06	0.00011	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NRAS—uterine cancer	2.45e-06	0.00011	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—uterine cancer	2.45e-06	0.00011	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	2.44e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NRAS—uterine cancer	2.44e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—uterine cancer	2.44e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NRAS—uterine cancer	2.43e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	2.43e-06	0.000109	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—uterine cancer	2.43e-06	0.000109	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NRAS—uterine cancer	2.41e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NRAS—uterine cancer	2.4e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—uterine cancer	2.39e-06	0.000107	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—uterine cancer	2.39e-06	0.000107	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—uterine cancer	2.37e-06	0.000106	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—uterine cancer	2.34e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—uterine cancer	2.33e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—uterine cancer	2.33e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—uterine cancer	2.3e-06	0.000103	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—uterine cancer	2.29e-06	0.000103	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—uterine cancer	2.26e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	2.26e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—uterine cancer	2.25e-06	0.000101	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	2.25e-06	0.000101	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—uterine cancer	2.24e-06	0.000101	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	2.24e-06	0.0001	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NRAS—uterine cancer	2.23e-06	0.0001	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	2.17e-06	9.77e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—uterine cancer	2.17e-06	9.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—uterine cancer	2.16e-06	9.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—uterine cancer	2.15e-06	9.67e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—uterine cancer	2.15e-06	9.65e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	2.14e-06	9.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—uterine cancer	2.12e-06	9.54e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—uterine cancer	2.12e-06	9.53e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—uterine cancer	2.11e-06	9.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—uterine cancer	2.11e-06	9.49e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—uterine cancer	2.11e-06	9.47e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—uterine cancer	2.11e-06	9.46e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—uterine cancer	2.1e-06	9.45e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—uterine cancer	2.1e-06	9.44e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—uterine cancer	2.1e-06	9.41e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—uterine cancer	2.08e-06	9.34e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—uterine cancer	2.08e-06	9.32e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—uterine cancer	2.07e-06	9.3e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—uterine cancer	2.07e-06	9.3e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—uterine cancer	2.07e-06	9.29e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—uterine cancer	2.07e-06	9.29e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—uterine cancer	2.02e-06	9.09e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—uterine cancer	2.01e-06	9.04e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—uterine cancer	1.98e-06	8.89e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—uterine cancer	1.97e-06	8.87e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—uterine cancer	1.97e-06	8.86e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—uterine cancer	1.95e-06	8.76e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.94e-06	8.72e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.94e-06	8.7e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—uterine cancer	1.93e-06	8.69e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	1.93e-06	8.67e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	1.93e-06	8.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.92e-06	8.64e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—uterine cancer	1.91e-06	8.57e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	1.91e-06	8.56e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—uterine cancer	1.9e-06	8.54e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	1.9e-06	8.54e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—uterine cancer	1.88e-06	8.45e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—uterine cancer	1.88e-06	8.44e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—uterine cancer	1.87e-06	8.42e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—uterine cancer	1.87e-06	8.39e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—uterine cancer	1.86e-06	8.36e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—uterine cancer	1.86e-06	8.36e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—uterine cancer	1.84e-06	8.29e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—uterine cancer	1.84e-06	8.28e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—uterine cancer	1.84e-06	8.26e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—uterine cancer	1.84e-06	8.25e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.83e-06	8.2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—uterine cancer	1.83e-06	8.2e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.8e-06	8.07e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—uterine cancer	1.79e-06	8.05e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—uterine cancer	1.79e-06	8.03e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—uterine cancer	1.78e-06	8e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—uterine cancer	1.78e-06	7.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.77e-06	7.93e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—uterine cancer	1.76e-06	7.92e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—uterine cancer	1.76e-06	7.9e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—uterine cancer	1.75e-06	7.85e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—uterine cancer	1.73e-06	7.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.71e-06	7.68e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—uterine cancer	1.65e-06	7.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.63e-06	7.34e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—uterine cancer	1.61e-06	7.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.59e-06	7.12e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—uterine cancer	1.58e-06	7.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—uterine cancer	1.58e-06	7.09e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—uterine cancer	1.58e-06	7.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—uterine cancer	1.57e-06	7.06e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—uterine cancer	1.56e-06	6.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—uterine cancer	1.55e-06	6.98e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.5e-06	6.72e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—uterine cancer	1.46e-06	6.56e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.44e-06	6.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.38e-06	6.18e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.36e-06	6.13e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—uterine cancer	1.28e-06	5.73e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—uterine cancer	1.22e-06	5.49e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—uterine cancer	1.22e-06	5.46e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—uterine cancer	1.19e-06	5.36e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.17e-06	5.24e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—uterine cancer	1.12e-06	5.05e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—uterine cancer	1.11e-06	5.01e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—uterine cancer	9.53e-07	4.28e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—uterine cancer	9e-07	4.04e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—uterine cancer	7.35e-07	3.3e-05	CbGpPWpGaD
